Rituximab, Cladribine, and Temsirolimus in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma

NCT00787969 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

74

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma

Interventions

BIOLOGICAL: rituximab
DRUG: cladribine
DRUG: temsirolimus
BIOLOGICAL: Filgrastim
BIOLOGICAL: Pegfilgrastim

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]